Mount Sinai Launches AI Small Molecule Drug Discovery Center (IMAGE)
Caption
Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai’s robust AI research enterprise, the center exemplifies the synergy between AI-driven initiatives, collaborating with key programs such as the recently announced Center for AI in Children's Health, which could identify novel targets for the drug discovery center to explore and potentially develop into new therapies.
Credit
Mount Sinai Health System
Usage Restrictions
May only be used in the context of this news.
License
Original content